Samsung Biologics plans fourth manufacturing plant within the year

Aug 11, 2020

In an online press conference, Samsung Biologics announced it plans for a fourth manufacturing plant within the year. This new US $2 billion plant will have 256KL capacity, with manufacturing activities scheduled to commence in the second half of 2022.

Print Page Mail Article